Twist Bioscience Corporation

NASDAQ:TWST

47.99 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Revenue 81.46475.30271.49866.94663.7460.1854.24357.30656.11348.12742.01837.95135.01831.20428.16132.43221.20719.29717.16415.73613.613.55711.4928.4076.5416.1664.3133.4663.176
Cost of Revenue 46.19344.4242.53642.42441.84541.66929.44231.58630.97429.71427.05622.49720.93319.02818.16217.57816.47213.56413.79212.38611.39411.78911.8579.0937.5038.0957.4986.8296.22
Gross Profit 35.27130.88228.96224.52221.89518.51124.80125.7225.13918.41314.96215.45414.08512.1769.99914.8544.7355.7333.3723.352.2061.768-0.365-0.686-0.962-1.929-3.185-3.363-3.044
Gross Profit Ratio 0.4330.410.4050.3660.3440.3080.4570.4490.4480.3830.3560.4070.4020.390.3550.4580.2230.2970.1960.2130.1620.13-0.032-0.082-0.147-0.313-0.738-0.97-0.958
Reseach & Development Expenses 22.46924.14923.09923.74524.52827.37931.24229.60636.8431.23122.6319.44319.83815.7911411.63610.44410.62910.29710.4969.0078.9077.2736.0655.2684.7114.3034.8515.277
General & Administrative Expenses 00044.49100051.75900028.7920028.79276.08222.48727.1926.40524.42321.3219.12415.25912.0530007.8090
Selling & Marketing Expenses 0002.90002.40009.451000-48.8970001.30000.90000.60
SG&A 56.79455.62252.8447.39146.05753.96542.32454.15953.69353.99851.09838.24334.47834.38928.79227.18522.48727.1926.40524.42321.3219.12415.25912.95311.2569.9789.2638.4095.919
Other Expenses -0.121-0.199-0.031-0.2450.041-0.305-0.157-0.461-0.225-0.245-0.156-1.064-0.3120.084-0.077-0.057-0.0560.018-0.087-0.002-0.227-0.021-0.015-0.045-0.014-0.043-0.019-0.2060
Operating Expenses 79.26379.77175.93971.13670.58581.34473.56683.76590.53385.22973.72857.68654.31650.1842.79238.82132.93137.81936.70234.91930.32728.03122.53219.01816.52414.68913.56613.2611.053
Operating Income -43.992-48.889-46.977-50.111-60.781-62.833-48.765-58.045-61.163-66.816-55.94-39.811-42.118-38.004-32.793-23.967-28.196-32.086-55.83-31.569-28.121-26.263-22.897-19.704-17.486-16.618-16.751-16.623-14.24
Operating Income Ratio -0.54-0.649-0.657-0.749-0.954-1.044-0.899-1.013-1.09-1.388-1.331-1.049-1.203-1.218-1.164-0.739-1.33-1.663-3.253-2.006-2.068-1.937-1.992-2.344-2.673-2.695-3.884-4.796-4.484
Total Other Income Expenses Net -41.3883.742-0.031-3.742-12.054.3537.0177.2224.0065.9992.671.357-2.1990.084-0.077-0.057-0.0560.018-22.587-0.002-0.227-0.021-0.015-0.045-0.014-0.043-0.019-0.206-0.007
Income Before Tax -85.38-45.147-42.888-46.464-56.773-58.48-41.748-50.823-60.666-60.817-55.968-40.9-42.414-37.858-32.854-24.055-28.186-31.707-55.601-31.07-27.862-25.849-22.596-19.726-17.553-16.83-16.885-16.89-14.247
Income Before Tax Ratio -1.048-0.6-0.6-0.694-0.891-0.972-0.77-0.887-1.081-1.264-1.332-1.078-1.211-1.213-1.167-0.742-1.329-1.643-3.239-1.974-2.049-1.907-1.966-2.346-2.684-2.729-3.915-4.873-4.486
Income Tax Expense 0.1910.3450.12-0.2210.6220.6760.0760.292-0.149-0.149-10.4050.34-2.3770.0610.0460.2630.0210.0610.0370.1110.0540.0840.0430.0760.0710.0430.0520.1190.07
Net Income -85.571-45.492-43.008-46.243-57.395-59.156-41.824-51.115-60.517-60.668-45.563-41.24-40.037-37.919-32.9-24.318-28.207-31.768-55.638-31.181-27.916-25.933-22.639-19.802-17.624-16.873-16.937-17.009-14.317
Net Income Ratio -1.05-0.604-0.602-0.691-0.9-0.983-0.771-0.892-1.078-1.261-1.084-1.087-1.143-1.215-1.168-0.75-1.33-1.646-3.242-1.982-2.053-1.913-1.97-2.355-2.694-2.736-3.927-4.907-4.508
EPS -1.47-0.79-0.75-0.81-1.01-1.04-0.74-0.91-1.08-1.13-0.91-0.84-0.82-0.78-0.72-0.55-0.67-0.85-1.69-0.96-0.92-0.93-1.18-0.74-0.94-0.9-0.9-0.91-6.02
EPS Diluted -1.47-0.79-0.75-0.81-1.01-1.04-0.74-0.91-1.08-1.13-0.91-0.84-0.82-0.78-0.72-0.54-0.67-0.85-1.69-0.96-0.92-0.93-1.18-0.74-0.94-0.9-0.9-0.91-6.02
EBITDA -35.692-40.589-34.717-42.966-44.681-59.674-45.882-56.578-64.897-62.834-58.768-43.238-40.457-35.299-32.736-23.912-28.005-31.492-32.853-30.782-27.544-25.509-22.248-18.011-15.519-15.098-15.326-15.395-12.982
EBITDA Ratio -0.438-0.539-0.486-0.642-0.701-0.992-0.846-0.987-1.157-1.306-1.399-1.139-1.155-1.131-1.162-0.737-1.321-1.632-1.914-1.956-2.025-1.882-1.936-2.142-2.373-2.449-3.553-4.442-4.088